menu
FR | EN
Medical assistance
Certified Medical Tourism ProfessionalBest Medical Travel Agency 2015Best use of technology in Medical Travel 2017

Highly accurate new blood test can detect early-stage lung cancer

10/02/2022

Highly accurate new blood test can detect early-stage lung cancer

The earlier lung cancer is diagnosed, the greater a patient's chances of survival. Now, a new test has could help with the detection of lung cancer in is early stages.


Developed by researchers at Peking University People’s Hospital in China, the novel non-invasive blood test assess levels of lipid biomarkers in patients' plasma samples.


While lung cancer screening techniques already exist, they often produce low accuracy results. And considering better treatment options and survival rates are associated with earlier detection, accuracy is key. In contrast, the new test, named Lung Cancer Artificial Intelligence Detector (LCAID), has high accuracy.


The study’s lead author, Jun Wang, chief of the Department of Thoracic Surgery at Peking University Peoples Hospital, explained:


“The accuracy and high specificity of LCAID might help improve the detection and screening of lung cancer and consequently reduce unnecessary exposure to radiation and invasive diagnostic procedures. Notably, most patients with lung cancer included in this study were at Stage I, and over 90% of them were correctly classified by LCAID.”


More information about the LCAID research can be found in Science Translational Medicine.


*Image courtesy of Belova59 from Pixabay 

expand_less